Those determined to outshine the market strategically focus on the selection of individual stocks. Well-chosen stocks have the potential to substantially boost your wealth.
The price of Nektar Therapeutics (NASDAQ: NKTR) closed at $0.74 in the last session, down -2.00% from day before closing price of $0.76. In other words, the price has decreased by -$2.00 from its previous closing price. On the day, 0.95 million shares were traded.
Ratios:
We take a closer look at NKTR’s different ratios to gain a better understanding of the stock. For the most recent quarter (mrq), Quick Ratio is recorded 4.26 and its Current Ratio is at 4.26. In the meantime, Its Debt-to-Equity ratio is 3.20 whereas as Long-Term Debt/Eq ratio is at 2.87.
On March 14, 2025, Oppenheimer Upgraded its rating to Outperform which previously was Perform but kept the price unchanged to $6.
On January 08, 2025, B. Riley Securities started tracking the stock assigning a Buy rating and target price of $4.B. Riley Securities initiated its Buy rating on January 08, 2025, with a $4 target price.
Insider Transactions:
An investor can also benefit from insider trades by learning what management is thinking about the future direction of stock prices. A recent insider transaction in this stock occurred on Feb 19 ’25 when Zalevsky Jonathan sold 10,300 shares for $1.01 per share. The transaction valued at 10,403 led to the insider holds 316,604 shares of the business.
Wilson Mark Andrew sold 11,040 shares of NKTR for $11,150 on Feb 19 ’25. The Chief Legal Officer now owns 324,292 shares after completing the transaction at $1.01 per share. On Feb 19 ’25, another insider, ROBIN HOWARD W, who serves as the President & CEO of the company, sold 23,774 shares for $1.01 each. As a result, the insider received 24,012 and left with 1,086,901 shares of the company.
Valuation Measures:
For the stock, the TTM Price-to-Sale (P/S) ratio is 1.40 while its Price-to-Book (P/B) ratio in mrq is 2.27.
Stock Price History:
Over the past 52 weeks, NKTR has reached a high of $1.93, while it has fallen to a 52-week low of $0.43. The 50-Day Moving Average of the stock is -2.86%, while the 200-Day Moving Average is calculated to be -29.87%.
Shares Statistics:
A total of 185.78M shares are outstanding, with a floating share count of 179.37M. Insiders hold about 3.62% of the company’s shares, while institutions hold 69.45% stake in the company.
